folic acid has been researched along with DDPAC in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Lv, X; Tang, C; Yin, C | 1 |
| Jia, J; Li, T; Quan, M; Song, Y | 1 |
| Abate, L; Amore, M; Cocito, L; Emberti Gialloreti, L; Guida, S; Krueger, F; Massucco, D; Mattei, C; Pardini, M; Sassos, D; Serrati, C | 1 |
1 trial(s) available for folic acid and DDPAC
| Article | Year |
|---|---|
Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study.
Topics: Aged; Choline; Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Executive Function; Female; Folic Acid; Frontotemporal Dementia; Humans; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Selenium; Social Skills; Synapses; Treatment Outcome; Uridine Monophosphate | 2015 |
2 other study(ies) available for folic acid and DDPAC
| Article | Year |
|---|---|
Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy.
Topics: Cell Line, Tumor; Chitosan; CRISPR-Cas Systems; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Frontotemporal Dementia; Humans; Nanoparticles; Neoplasms; Plasmids; RNA Interference; Survivin | 2022 |
Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia.
Topics: Alzheimer Disease; Cognitive Dysfunction; Dementia, Vascular; Folic Acid; Frontotemporal Dementia; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B 12 | 2022 |